EGFR and non-small cell lung carcinoma: The same group also evaluated the impact of chemotherapy, radiotherapy or epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) effect on the TME (PD-L1 levels) of NSCLC.